SUNY funds Binghamton AI cancer diagnostics and RNA delivery research
Binghamton University researchers received SUNY seed funding to develop an AI pathology model and an amino-acid-based nanoparticle platform for delivering ...
Binghamton University researchers received SUNY seed funding to develop an AI pathology model and an amino-acid-based nanoparticle platform for delivering ...
A PLoS Biology perspective argues that the real challenge in treating neurodegenerative disease is no longer crossing the blood–brain barrier, ...
A Journal of Translational Medicine review outlines how mRNA-encoded antibodies, bispecific constructs, and transient CAR expression could overcome the manufacturing ...
A collaborative laboratory study found that storage-buffer choice can change the structure, stability and cell-delivery performance of mRNA lipid nanoparticles ...
An AI-guided lipid nanoparticle formulation remained functional after two months at 37 degrees Celsius or one year at room temperature ...
A 2026 review summarizes advances in CRISPR-Cas9 precision, delivery and primary-cell engineering for genetic diseases and diabetes, while the available ...
A new cross-platform review of eighteen FDA-approved RNA therapeutics finds that adverse effects depend more on delivery chemistry and administration ...
A new review charts how in vivo CAR-T engineering could transform customized living drugs into scalable, off-the-shelf genetic medicines.
Infant neuroblastoma is one of the most clinically paradoxical cancers in medicine. Diagnosed during the first year of life, it ...
A new hypothesis proposes that programmable lipid nanoparticles may shape cellular memory systems to extend the durability of mRNA vaccines ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine